ES457385A1 - Procedimiento para preparar derivados de prostaglandinas. - Google Patents

Procedimiento para preparar derivados de prostaglandinas.

Info

Publication number
ES457385A1
ES457385A1 ES457385A ES457385A ES457385A1 ES 457385 A1 ES457385 A1 ES 457385A1 ES 457385 A ES457385 A ES 457385A ES 457385 A ES457385 A ES 457385A ES 457385 A1 ES457385 A1 ES 457385A1
Authority
ES
Spain
Prior art keywords
methyl
same
ethyl
preparing
prostaglandin derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES457385A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Labaz SA
Original Assignee
Labaz SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Labaz SA filed Critical Labaz SA
Publication of ES457385A1 publication Critical patent/ES457385A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/126—Acids containing more than four carbon atoms
    • C07C53/128—Acids containing more than four carbon atoms the carboxylic group being bound to a carbon atom bound to at least two other carbon atoms, e.g. neo-acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Procedimiento para preparar derivados de prostaglandinas, de fórmula general: (*ver imagen I), en la R2, R3 y R4, que son iguales o diferentes, representan cada uno hidrógeno o metilo.
ES457385A 1976-03-31 1977-03-31 Procedimiento para preparar derivados de prostaglandinas. Expired ES457385A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL49325A IL49325A (en) 1976-03-31 1976-03-31 8-aza-11-deoxy-pge1 derivatives,their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
ES457385A1 true ES457385A1 (es) 1978-02-01

Family

ID=11048789

Family Applications (1)

Application Number Title Priority Date Filing Date
ES457385A Expired ES457385A1 (es) 1976-03-31 1977-03-31 Procedimiento para preparar derivados de prostaglandinas.

Country Status (18)

Country Link
US (1) US4115401A (es)
JP (1) JPS52142060A (es)
BE (1) BE852941A (es)
CA (1) CA1074804A (es)
CH (2) CH624101A5 (es)
DD (1) DD130352A5 (es)
DE (1) DE2714129A1 (es)
ES (1) ES457385A1 (es)
FR (1) FR2346332A1 (es)
GB (1) GB1574246A (es)
HU (1) HU178040B (es)
IL (1) IL49325A (es)
IT (1) IT1075373B (es)
NL (1) NL7703503A (es)
NO (1) NO149428C (es)
PL (3) PL108289B1 (es)
SE (1) SE417603B (es)
SU (3) SU676162A3 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2927855A1 (de) * 1978-07-11 1980-03-20 Glaxo Group Ltd Prostanoid-verbindungen
US4320136A (en) * 1980-08-11 1982-03-16 E. I. Du Pont De Nemours And Company 8-Aza-16,16-difluoroprostanoids
US4530933A (en) * 1982-12-27 1985-07-23 E. I. Du Pont De Nemours And Company 8-Aza-13-thiaprostanoids and a method of use thereof as anti-ulcer agents
US4456613A (en) * 1982-12-27 1984-06-26 E. I. Du Pont De Nemours And Company 6-Keto- and 6-hydroxy-8-azaprostanoids and anti-ulcer use thereof
MXPA02006322A (es) 1999-12-22 2002-12-13 Pfizer Prod Inc Agonistas selectivos del receptor ep4 en el tratamiento de la osteoporosis.
DK1339678T3 (da) * 2000-11-27 2008-02-04 Pfizer Prod Inc Selektive agonister til EP4-receptor til behandling af osteoporose
JP2004521954A (ja) 2001-07-16 2004-07-22 エフ．ホフマン−ラ　ロシュ　アーゲー Ｅｐ４受容体作用薬としてのプロスタグランジン類似体
MXPA04000454A (es) * 2001-07-16 2004-03-18 Hoffmann La Roche Derivados de 2-pirrolidona como agonistas de prostanoides.
CA2454584C (en) * 2001-07-23 2009-09-22 Ono Pharmaceutical Co., Ltd. Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient
KR100704215B1 (ko) 2002-03-05 2007-04-10 오노 야꾸힝 고교 가부시키가이샤 8-아자프로스타글란딘 유도체 화합물 및 그 화합물을 유효성분으로서 함유하는 약제
EP1490055A1 (en) * 2002-03-18 2004-12-29 Pfizer Products Inc. Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
RU2311409C2 (ru) * 2003-01-10 2007-11-27 Ф.Хоффманн-Ля Рош Аг Производные 2-пиперидона в качестве агонистов простагландина
US7179820B2 (en) 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
US20080058375A1 (en) * 2004-01-08 2008-03-06 Elworthy Todd R 2-Piperidone derivatives as prostaglandin antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones

Also Published As

Publication number Publication date
PL107643B1 (pl) 1980-02-29
SE7703698L (sv) 1977-10-01
GB1574246A (en) 1980-09-03
SE417603B (sv) 1981-03-30
SU837321A3 (ru) 1981-06-07
US4115401A (en) 1978-09-19
SU715019A3 (ru) 1980-02-05
IT1075373B (it) 1985-04-22
PL108289B1 (pl) 1980-03-31
DD130352A5 (de) 1978-03-22
JPS52142060A (en) 1977-11-26
IL49325A0 (en) 1976-05-31
BE852941A (fr) 1977-09-28
HU178040B (en) 1982-02-28
PL197005A1 (pl) 1978-10-09
PL107544B1 (pl) 1980-02-29
DE2714129A1 (de) 1977-10-13
NL7703503A (nl) 1977-10-04
CH624101A5 (es) 1981-07-15
NO771134L (no) 1977-10-03
FR2346332B1 (es) 1980-05-09
IL49325A (en) 1979-11-30
FR2346332A1 (fr) 1977-10-28
CA1074804A (en) 1980-04-01
SU676162A3 (ru) 1979-07-25
NO149428B (no) 1984-01-09
CH628032A5 (fr) 1982-02-15
NO149428C (no) 1984-04-18

Similar Documents

Publication Publication Date Title
ES457385A1 (es) Procedimiento para preparar derivados de prostaglandinas.
ES461762A1 (es) Un procedimiento para preparar una composicion tintorea parafibras queratinicas.
ES448263A1 (es) Procedimiento para la obtencion de materiales sinteticos de poliuretano.
ES431059A1 (es) Procedimiento para la preparacion de nuevos n-(metoximetil - furilmetil)-6, 7-benzomorfanos y -morfinanos.
ES438684A1 (es) Procedimiento para preparar derivados de 2-fenil-indol.
ES448475A1 (es) Procedimiento de preparacion de derivados triyodados del benceno.
ES8104391A1 (es) Un procedimiento para preparar una composicion tensioactiva de baja formacion de espuma
ES482005A1 (es) Procedimiento para preparar una composicion tensioactiva de-alcoxi-bis (trialcoxisiloxi)- silano.
ES484962A1 (es) Procedimiento para la obtencion de compuestos amonicos cua- ternarios
ES485096A1 (es) Un procedimiento para preparar aminoglicosidos
ES478507A1 (es) Procedimiento para la preparacion de derivados alfa-acetile-nicos de alfa-animo acidos.
ES473464A1 (es) Procedimiento para la preparacion de nuevos derivados de 5,-11-dihidro-6h-pirido (2,3-b)(1,4)benzodiazepin-6-ona.
ES447922A1 (es) Procedimiento de preparacion de nuevos derivados sustitui- dos en n de la fenil-piperidina.
ES443912A1 (es) Procedimiento para preparar derivados del acido fenil-aceti-co.
ATE13880T1 (de) N-2-hydroxypropyl-piperidine und verfahren zu ihrer herstellung.
HUT57179A (en) Hydroxyalkanecarboxylic acid derivatives, process for producing same and their application
ES463424A1 (es) Procedimiento de preparacion de lactamas sustituidas en n.
ES438234A1 (es) Un procedimiento para la preparacion de derivados de oxici- clohexano.
ES433816A1 (es) Procedimiento para preparar derivados de amidoxina.
ES440723A1 (es) Procedimiento para la produccion de nuevos compuestos orga- nicos.
ES8505806A1 (es) Procedimiento para preparar nuevas sales de alquil(mixto) sulfonio de n-fosfonome-tilglicina
ES8200648A2 (es) Procedimiento de preparacion de compuestos opacificantes para radiografia y similares
ES455158A1 (es) Procedimiento para la preparacion de derivados de di-n-oxidode quinoxalina.
ES467861A1 (es) Procedimiento de preparacion de espiro-oxazolidinas esteroi-des y sus esteroisomeros.
ES471267A1 (es) Procedimiento para la preparacion de alquilo inferior 2-tri-(inferior) alquilsililacetileno-n-carbetoxiglicinatos y ami-no acidos derivados de ellos